BOEING CO (BA)
Income Statement
Consolidated Statement of Income
BOEING CO (BA-PRA)
Year Ended (In millions, except shares and per share data)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | |
|---|---|---|---|
| Total revenues | $89,463 | $66,517 | $77,794 |
| Sales of products | $75,356 | $53,227 | $65,581 |
| Sales of services | $14,107 | $13,290 | $12,213 |
| Cost of goods and services sold | $(85,174) | $(68,508) | $(70,070) |
| Sales of products | $(73,761) | $(57,394) | $(59,864) |
| Sales of services | $(11,413) | $(11,114) | $(10,206) |
| Total costs and expenses | $(85,174) | $(68,508) | $(70,070) |
| Gross profit | $4,289 | $(1,991) | $7,724 |
| Income from operating investments, net | $25 | $71 | $46 |
| General and administrative expense | $(6,090) | $(5,021) | $(5,168) |
| Research and development expense, net | $(3,615) | $(3,812) | $(3,377) |
| Gain on dispositions, net | $(9,672) | $(46) | $(2) |
| Earnings/(loss) from operations | 4,281 | (10,707) | (773) |
| Other income, net | $1,125 | $1,222 | $1,227 |
| Interest and debt expense | $(2,771) | $(2,725) | $(2,459) |
| Earnings/(loss) before income taxes | $2,635 | $(12,210) | $(2,005) |
| Income tax (expense)/benefit | $(397) | $381 | $(237) |
| Net earnings/(loss) | $2,238 | $(11,829) | $(2,242) |
| Less: Net earnings/(loss) attributable to noncontrolling interest | $3 | $(12) | $(20) |
| Net earnings/(loss) attributable to Boeing shareholders | $2,235 | $(11,817) | $(2,222) |
| Less: Mandatory convertible preferred stock dividends accumulated during the period | $345 | $58 | |
| Net earnings/(loss) attributable to Boeing common shareholders | $1,890 | $(11,875) | $(2,222) |
| Net earnings/(loss) attributable to Boeing common shareholders | $1,890 | $(11,875) | $(2,222) |
| Basic earnings/(loss) per share (in dollars per share) | 2.49 | -18.36 | -3.67 |
| Diluted earnings/(loss) per share (in dollars per share) | 2.48 | -18.36 | -3.67 |
Balance Sheet
Consolidated Balance Sheets
BOEING CO (BA-PRA)
As of December 31, 2025 and December 31, 2024 (In millions, except shares and per share data)
| Dec 31, 2025 | Dec 31, 2024 | |
|---|---|---|
| Cash and cash equivalents | $10,921 | $13,801 |
| Short-term and other investments | $18,479 | $12,481 |
| Accounts receivable, net | $2,921 | $2,631 |
| Unbilled receivables, net | $9,158 | $8,363 |
| Current portion of financing receivables, net | $207 | |
| Inventories | $84,679 | $87,550 |
| Other current assets, net | $2,301 | $2,965 |
| Total current assets | $128,459 | $127,998 |
| Financing receivables and operating lease equipment, net | $241 | $314 |
| Property, plant and equipment, net | $15,361 | $11,412 |
| Goodwill | $17,275 | $8,084 |
| Acquired intangible assets, net | $1,567 | $1,957 |
| Deferred income taxes | $107 | $185 |
| Investments | $1,048 | $999 |
| Other assets, net of accumulated amortization of $1,014 and $1,085 | $4,177 | $5,414 |
| Total assets | $168,235 | $156,363 |
| Accounts payable | $13,109 | $11,364 |
| Accrued liabilities | $27,141 | $24,103 |
| Advances and progress billings | $59,404 | $60,333 |
| Short-term debt and current portion of long-term debt | $8,461 | $1,278 |
| Total current liabilities | $108,115 | $97,078 |
| Deferred income taxes | $216 | $122 |
| Accrued retiree health care | $2,091 | $2,176 |
| Accrued pension plan liability, net | $4,287 | $5,997 |
| Other long-term liabilities | $2,432 | $2,318 |
| Long-term debt | $45,637 | $52,586 |
| Total liabilities | $162,778 | $160,277 |
| Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750 | $6 | $6 |
| Mandatory convertible preferred stock | $6 | $6 |
| Common stock, par value $5.00 – 1,200,000,000 shares authorized; 1,012,261,159 shares issued | $5,061 | $5,061 |
| Additional paid-in capital | $21,441 | $18,964 |
| Treasury stock, at cost | $(28,029) | $(32,386) |
| Retained earnings | $17,252 | $15,362 |
| Accumulated other comprehensive loss | $(10,277) | $(10,915) |
| Total shareholders' equity/(deficit) | $5,454 | $(3,908) |
| Noncontrolling interests | $3 | $(6) |
| Total equity | $5,457 | $(3,914) |
| Total liabilities and equity | $168,235 | $156,363 |
Cash Flow
Consolidated Statement of Cash Flows
BOEING CO (BA-PRA)
Year Ended (In millions, except shares and per share data)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | |
|---|---|---|---|
| Net earnings/(loss) | $2,238 | $(11,829) | $(2,242) |
| Share-based plans expense | $426 | $407 | $690 |
| Treasury shares issued for 401(k) contribution | $1,530 | $1,601 | $1,515 |
| Depreciation and amortization | $1,953 | $1,836 | $1,861 |
| Investment/asset impairment charges, net | $45 | $112 | $46 |
| Operating Lease Assets | $5 | ||
| Gain on dispositions, net | $(9,672) | $(46) | $(2) |
| 777X and 767 reach-forward losses | $5,283 | $4,079 | |
| Airplane Program 777x | $4,899 | $3,499 | |
| Other charges and credits, net | $264 | $528 | $3 |
| Accounts receivable | $(95) | $(37) | $(128) |
| Unbilled receivables | $(677) | $(60) | $321 |
| Advances and progress billings | $(723) | $4,069 | $3,365 |
| Inventories | $(1,501) | $(12,353) | $(1,681) |
| Other current assets | $155 | $(16) | $389 |
| Accounts payable | $724 | $(793) | $1,672 |
| Accrued liabilities | $1,341 | $1,563 | $779 |
| Income taxes receivable, payable and deferred | $115 | $(567) | $44 |
| Other long-term liabilities | $(346) | $(329) | $(313) |
| Pension and other postretirement plans | $(593) | $(959) | $(1,049) |
| Financing receivables and operating lease equipment, net | $274 | $512 | $571 |
| Other | $324 | $202 | $119 |
| Net cash provided/(used) by operating activities | $1,065 | $(12,080) | $5,960 |
| Payments to acquire property, plant and equipment | $(2,942) | $(2,230) | $(1,527) |
| Proceeds from disposals of property, plant and equipment | $82 | $49 | $27 |
| Acquisitions, net of cash acquired | $(1,248) | $(50) | $(70) |
| Proceeds from dispositions | $10,585 | $124 | |
| Contributions to investments | $(51,938) | $(13,856) | $(16,448) |
| Time Deposits | $(51,295) | $(13,258) | $(15,794) |
| Proceeds from investments | $46,628 | $4,743 | $15,739 |
| Time Deposits | $46,025 | $4,053 | $15,140 |
| Supplier notes receivable | $(662) | $(694) | $(162) |
| Repayments on supplier notes receivable | $2 | $40 | |
| Purchase of distribution rights | $(9) | $(88) | |
| Other | $1 | $(11) | $4 |
| Net cash provided/(used) by investing activities | $499 | $(11,973) | $(2,437) |
| New borrowings | $165 | $10,161 | $75 |
| Debt repayments | $(3,621) | $(8,673) | $(5,216) |
| Common stock issuance, net of issuance costs | $18,200 | ||
| Mandatory convertible preferred stock issuance, net of issuance costs | $5,657 | ||
| Stock options exercised | $45 | ||
| Employee taxes on certain share-based payment arrangements | $(34) | $(83) | $(408) |
| Dividends paid on Mandatory convertible preferred stock | $(331) | ||
| Mandatory convertible preferred stock | $(331) | ||
| Other | $58 | $(53) | $17 |
| Net cash (used)/provided by financing activities | $(3,763) | $25,209 | $(5,487) |
| Effect of exchange rate changes on cash and cash equivalents | $40 | $(47) | $30 |
| Net (decrease)/increase in cash & cash equivalents, including restricted | $(2,159) | $1,109 | $(1,934) |
| Cash & cash equivalents, including restricted, at end of year | |||
| Cash & cash equivalents, including restricted, at end of year | |||
| Less restricted cash & cash equivalents, included in Investments | |||
| Cash and cash equivalents at end of year |